NIH 2020 R44 CA |
Commercialization of a proprietary Ga-68 PSMA-targeted drug for PET imaging in recurrent prostate cancer Alexoff, David / Five Eleven Pharma, Inc. |
|
NIH 2019 R44 CA |
Commercialization of a proprietary Ga-68 PSMA-targeted drug for PET imaging in recurrent prostate cancer Alexoff, David / Five Eleven Pharma, Inc. |
|
NIH 2018 R44 CA |
Commercialization of a proprietary Ga-68 PSMA-targeted drug for PET imaging in recurrent prostate cancer Alexoff, David / Five Eleven Pharma, Inc. |
|